唯捷創芯(688153.SH):下一代面向中高端市場的高集成度模組phase 8方案還處於產品定義和架構設計階段
格隆匯11月27日丨有投資者向唯捷創芯(688153.SH)提問:phase 8方案的定義與需求和公司技術儲備情況。
唯捷創芯回覆:下一代面向中高端市場的高集成度模組phase 8方案還處於產品定義和架構設計階段,預計2025年才能迎來真正的商用化。相較於現有的phase 7LE產品,預計新方案除了將在產品面積、性能等方面進行優化和提升,還將支持更多新的頻段和功能,例如衞星通信等。基於公司已經大規模量產銷售phase 7LE的模組產品,積累了相關技術,模組化能力得到廣泛認可,公司正與平台廠商和終端品牌客户展開合作,參與到phase 8方案的產品定義中,目前公司與國際廠商在這代產品上的研發進展基本同步。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.